Aptahem strengthens team ahead of clinical Phase I of Apta-1
(WorldNews Health)

Aptahem today announced that the company is expanding its team with Suzanne Kilany as Clinical Research Director for the next step in the development of the company`s lead drug candidate, Apta-1. Suzanne will primarily lead and coordinate the planning and preparation work for the clinical phase I program of Apta-1. Suzanne Kilany is a registered nurse and has worked as oncology nurse for many years. She has also over...